BIOMARIN PHARMACEUTICAL INC revenue for the last year amounted to 41.09 B MXN, the most of which — 41.09 B MXN — came from its highest performing source at the moment, Innovative Therapies, the year earlier bringing 40.88 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought BIOMARIN PHARMACEUTICAL INC 13.10 B MXN, and the year before that — 13.35 B MXN.